Rocket Lab Corporation (NASDAQ:RKLB - Get Free Report) SVP Arjun Kampani sold 31,185 shares of the firm's stock in a transaction that occurred on Tuesday, September 16th. The stock was sold at an average price of $48.97, for a total transaction of $1,527,129.45. Following the transaction, the senior vice president owned 499,045 shares in the company, valued at approximately $24,438,233.65. This trade represents a 5.88% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Arjun Kampani also recently made the following trade(s):
- On Wednesday, September 17th, Arjun Kampani sold 9,416 shares of Rocket Lab stock. The shares were sold at an average price of $47.70, for a total transaction of $449,143.20.
Rocket Lab Stock Down 1.9%
NASDAQ RKLB traded down $0.90 on Thursday, hitting $47.18. 19,308,755 shares of the company's stock were exchanged, compared to its average volume of 21,560,860. The firm's 50-day moving average price is $46.06 and its two-hundred day moving average price is $31.75. Rocket Lab Corporation has a fifty-two week low of $7.00 and a fifty-two week high of $55.17. The company has a debt-to-equity ratio of 0.60, a quick ratio of 2.33 and a current ratio of 2.67.
Rocket Lab (NASDAQ:RKLB - Get Free Report) last issued its earnings results on Thursday, August 7th. The rocket manufacturer reported ($0.13) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.07) by ($0.06). The company had revenue of $144.50 million during the quarter, compared to analysts' expectations of $135.42 million. Rocket Lab had a negative net margin of 45.87% and a negative return on equity of 48.14%. The company's quarterly revenue was up 35.9% on a year-over-year basis. During the same period last year, the business posted ($0.08) earnings per share. Rocket Lab has set its Q3 2025 guidance at EPS. On average, sell-side analysts anticipate that Rocket Lab Corporation will post -0.38 earnings per share for the current year.
Hedge Funds Weigh In On Rocket Lab
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Truist Financial Corp boosted its stake in Rocket Lab by 1.9% during the 2nd quarter. Truist Financial Corp now owns 12,352 shares of the rocket manufacturer's stock valued at $442,000 after purchasing an additional 234 shares during the period. Parvin Asset Management LLC increased its holdings in Rocket Lab by 7.2% in the 2nd quarter. Parvin Asset Management LLC now owns 3,725 shares of the rocket manufacturer's stock valued at $133,000 after buying an additional 250 shares during the period. GAMMA Investing LLC raised its position in Rocket Lab by 36.4% in the second quarter. GAMMA Investing LLC now owns 1,518 shares of the rocket manufacturer's stock worth $54,000 after purchasing an additional 405 shares in the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Rocket Lab by 109.5% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 796 shares of the rocket manufacturer's stock worth $28,000 after buying an additional 416 shares in the last quarter. Finally, Allworth Financial LP raised its stake in Rocket Lab by 4.0% during the first quarter. Allworth Financial LP now owns 11,888 shares of the rocket manufacturer's stock worth $213,000 after acquiring an additional 458 shares in the last quarter. Institutional investors and hedge funds own 71.78% of the company's stock.
Wall Street Analyst Weigh In
Several analysts have recently issued reports on the stock. The Goldman Sachs Group began coverage on Rocket Lab in a report on Monday, June 30th. They set a "neutral" rating and a $27.00 price objective for the company. Cantor Fitzgerald increased their price target on Rocket Lab from $35.00 to $54.00 and gave the company an "overweight" rating in a report on Friday, August 8th. Bank of America upped their price objective on Rocket Lab from $30.00 to $50.00 and gave the company a "buy" rating in a research note on Wednesday, July 16th. Needham & Company LLC reaffirmed a "buy" rating and set a $55.00 target price on shares of Rocket Lab in a report on Wednesday, September 3rd. Finally, Roth Capital reaffirmed a "buy" rating on shares of Rocket Lab in a research note on Friday, August 29th. One investment analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating and four have given a Hold rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and a consensus target price of $42.27.
Read Our Latest Analysis on RKLB
Rocket Lab Company Profile
(
Get Free Report)
Rocket Lab USA, Inc, a space company, provides launch services and space systems solutions for the space and defense industries. The company provides launch services, spacecraft design services, spacecraft components, spacecraft manufacturing, and other spacecraft and on-orbit management solutions; and constellation management services, as well as designs and manufactures small and medium-class rockets.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Rocket Lab, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rocket Lab wasn't on the list.
While Rocket Lab currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.